Skip to content

Thyroid Hormones: Testing, Hypothyroidism, and Hyperthyroidism

Last updated

Written and fact-checked by the Hormone Hero editorial team against the sources listed below. Not yet reviewed by a licensed clinician. How we work

Strong evidence · 5 sources

Multiple high-quality trials, systematic reviews, or clinical guidelines agree. Further research is unlikely to overturn the conclusion. How we grade evidence



Thyroid hormones set the pace for energy use, temperature regulation, and much of the body’s metabolic machinery. This hub summarizes what major guidelines say about testing, underactive and overactive thyroid disease, and pregnancy — and where the evidence stops short of popular claims.

Key facts

  • TSH is the usual first test for outpatient thyroid dysfunction; free T4 (and sometimes free T3) refine the picture when TSH is abnormal.1
  • Overt hypothyroidism is treated with levothyroxine to normalize TSH; combination T4/T3 therapy is not first-line for most adults.12
  • Hyperthyroidism and thyrotoxicosis have multiple causes; management depends on the diagnosis (for example Graves disease versus toxic nodule) and patient factors.3
  • Thyroid disease in pregnancy uses trimester-specific interpretation and separate ATA guidance — not ordinary adult cutoffs alone.4
  • This page is educational, not a diagnosis or dosing protocol. Individual decisions belong with a licensed clinician.

What the thyroid does

The thyroid gland produces thyroxine (T4) and triiodothyronine (T3). The pituitary releases thyroid-stimulating hormone (TSH) to keep circulating thyroid hormone in a narrow range. When thyroid hormone is low, TSH typically rises; when hormone is high, TSH falls. That feedback loop is why TSH is so useful as a screening test — and why a single free T3 level, taken out of context, is a poor way to “optimize” thyroid status in people who feel unwell but have normal TSH and free T4.

Testing: TSH, free T4, free T3

Guideline-directed care for ambulatory adults usually starts with TSH. If TSH is abnormal, free T4 helps classify overt versus subclinical disease. Free T3 has a narrower role (for example in assessing certain forms of thyrotoxicosis) and is not a substitute for TSH as a general “thyroid wellness” panel.13

Antibody tests (such as TPO antibodies) can support a diagnosis of autoimmune thyroid disease but do not, by themselves, define whether treatment is needed. Imaging and uptake studies are reserved for specific questions — nodules, hyperthyroidism etiology — not for everyone with fatigue.

Pattern (simplified)Typical lab pictureWhat it usually means
Overt hypothyroidismHigh TSH, low free T4Underactive thyroid; treatment is usually indicated
Subclinical hypothyroidismHigh TSH, normal free T4Borderline underactivity; treatment depends on TSH level, symptoms, antibodies, and pregnancy plans
Overt hyperthyroidismLow TSH, high free T4 and/or free T3Excess thyroid hormone; needs cause-specific evaluation
Subclinical hyperthyroidismLow TSH, normal free T4/T3Mild excess signal; management depends on degree of TSH suppression and risk (for example atrial fibrillation, bone)

These patterns are a map, not a diagnosis. Medications, acute illness, assay interference, and pituitary disease can all scramble the usual relationships between TSH and free hormone levels.

Hypothyroidism

Hypothyroidism means the body is not producing enough thyroid hormone for needs. Common causes in iodine-sufficient regions include autoimmune (Hashimoto) thyroiditis and prior thyroid surgery or radioiodine. Clinical practice guidelines co-sponsored by AACE and the American Thyroid Association describe evidence-based outpatient management, including who to treat and how to monitor levothyroxine replacement.1

A later ATA task force focused specifically on treatment of hypothyroidism and reaffirmed levothyroxine monotherapy as standard for most patients, while reviewing the evidence (and limits of evidence) for T3-containing regimens in selected situations.2

What the guidelines do not support as routine care: “optimizing” free T3 into a preferred range while TSH is already normal; treating every mildly elevated TSH the same way regardless of age and comorbidity; or assuming that residual symptoms on adequate levothyroxine always mean a need for T3. Residual symptoms deserve a careful workup — they are not automatically proof of undertreated thyroid disease.

Hyperthyroidism and thyrotoxicosis

Thyrotoxicosis is the clinical state of excess thyroid hormone action. Hyperthyroidism is one cause (the gland overproduces hormone); other causes include thyroiditis with hormone leakage or excess exogenous hormone. The 2016 ATA guidelines for hyperthyroidism and other causes of thyrotoxicosis walk through evaluation (including when to use uptake scans or antibody testing) and treatment options: antithyroid drugs, radioactive iodine, and surgery, each with different tradeoffs.3

Graves disease, toxic multinodular goiter, and toxic adenoma are not interchangeable. Pregnancy, orbitopathy, heart disease, and patient preference all change the preferred path. That is why self-directed antithyroid drug use or “natural” regimens that claim to replace endocrine care are unsafe territory for a reference page to recommend.

Pregnancy and the postpartum

Thyroid physiology shifts in pregnancy: human chorionic gonadotropin can suppress TSH early, binding proteins change free hormone interpretation, and iodine needs rise. The 2017 ATA guidelines for thyroid disease during pregnancy and the postpartum provide recommendations on testing interpretation, iodine, autoimmunity, hypo- and hyperthyroidism in pregnancy, nodules, and postpartum thyroiditis.4

Universal screening versus case-finding remains debated in some health systems; what is not debated is that women with known thyroid disease need coordinated care before and during pregnancy. Do not treat online reference ranges as pregnancy targets.

Nodules and cancer (brief)

Many adults have thyroid nodules; most are benign. The 2015 ATA guidelines on nodules and differentiated thyroid cancer describe ultrasound risk features, when fine-needle aspiration is indicated, and risk-adapted management after cancer diagnosis.5 A nodule found on a neck scan is not an emergency by default, but it is a reason for structured evaluation rather than either panic or neglect.

What we are not claiming

  • We do not provide dosing tables, brand recommendations, or “natural desiccated thyroid is always better” conclusions.
  • We do not diagnose autoimmune disease from symptoms alone.
  • We do not treat “adrenal fatigue” as a synonym for thyroid disease; that framing is not a guideline diagnosis.
  • We do not link to clinics, pharmacies, or supplement funnels.

FAQ

Is a normal TSH enough to rule out thyroid disease?

For most outpatients with nonspecific symptoms, a normal TSH makes clinically important thyroid dysfunction unlikely. It does not rule out every rare pituitary or assay problem, and it does not explain every symptom people attribute to “thyroid.” Context still matters.1

Should everyone with a slightly high TSH take levothyroxine?

No. Subclinical hypothyroidism is managed based on TSH degree, age, cardiovascular risk, antibodies, symptoms, and pregnancy status. Guidelines do not treat every number above the lab’s upper limit the same way.12

Is T3 (liothyronine) better than T4 alone?

Levothyroxine (T4) monotherapy is standard for most adults. Evidence for routine T4/T3 combination therapy is mixed; selected patients may discuss a supervised trial with a clinician, but it is not the default path in major guidance.2

I have Graves disease — is radioactive iodine always required?

No. Antithyroid drugs, radioactive iodine, and surgery are all valid options depending on disease severity, orbitopathy, pregnancy plans, and preference. The ATA hyperthyroidism guideline outlines how those choices are weighed.3

References

  1. Garber JR, Cobin RH, Gharib H, et al.. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice 2012. Clinical practice guideline PMID: 23246686
  2. Jonklaas J, Bianco AC, Bauer AJ, et al.. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 2014. Clinical practice guideline PMID: 25266247
  3. Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016. Clinical practice guideline PMID: 27521067
  4. Alexander EK, Pearce EN, Brent GA, et al.. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 2017. Clinical practice guideline PMID: 28056690
  5. Haugen BR, Alexander EK, Bible KC, et al.. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016. Clinical practice guideline PMID: 26462967